BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Fresenius SE & Co KGaA

Uždarymo kaina

SektoriusSveikatos priežiūra

39.86 -0.2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

39.7

Max

40.25

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-48M

271M

Pardavimai

264M

5.6B

P/E

Sektoriaus vid.

24.381

57.333

Pelno marža

4.813

Darbuotojai

176,486

EBITDA

-33M

724M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+17.39% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.1B

22B

Ankstesnė atidarymo kaina

40.06

Ankstesnė uždarymo kaina

39.86

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Fresenius SE & Co KGaA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-26 13:37; UTC

Rinkos pokalbiai

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

2024-06-05 12:18; UTC

Rinkos pokalbiai

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Akcijų palyginimas

Kainos pokytis

Fresenius SE & Co KGaA Prognozė

Kainos tikslas

By TipRanks

17.39% į viršų

12 mėnesių prognozė

Vidutinis 46.78 EUR  17.39%

Aukščiausias 56.9 EUR

Žemiausias 42 EUR

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fresenius SE & Co KGaA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

11

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

39.5 / 39.92Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.